Hydra Royal is a modular treatment designed for multi-level skin revitalization. Thanks to the multi-stage treatment sequence, it conditions and stimulates all layers of the skin, starting from the epidermis and ending with deep skin structures. Innovative stimulator and biorevitalizant based on highly concentrated hyaluronic acid 60mg / 3ml, for immediate improvement of hydration, smoothing and tightening of the skin. Dedicated to the strong smoothing of superficial wrinkles, thickening the skin structure and conditioning of the skin requiring strong renewal and revitalization. The use of as much as 60mg of hyaluronic acid with a high molecular weight makes it one of the strongest rejuvenating products in its category. In addition, thanks to the use of the Aqua-Oxygen Hybrid II technology patent pending in the production process, hyaluronic acid is aerated and hydrated, thanks to which it increases its elasticity and hygroscopic capabilities. At the final stage of production, specially selected acid molecules are secured with an admixture of a cross-linking agent, thanks to which, in addition to exceptional revitalizing properties, they also gain a long-lasting release system. The advanced production system, unique technology, extremely high acid concentration, a slight degree of cross-linking, as well as the possibility of administering the product using up to 6 techniques and treatment protocols make Hydra Royal redefine skin rejuvenation and revitalization. INDICATIONS • progressive aging and tissue atrophy • numerous wrinkles and skin creases • dehydration and dry skin • photoaging and solar elastosis • paragraph refreshing MODE OF ACTION • supplementation of endogenous hyaluronic acid • reducing skin dryness and dehydration wrinkles • filling mimic and chronological wrinkles • restoring the natural density and tension of the skin • improvement of tissue hydration and hydration • optimizing the metabolic and functional processes of the skin • stimulation of collagen and elastin synthesis HA acid concentration: 60mg / 3ml Treatment series: 4 treatments every 10-14 days Capacity: 3x1ml Treatment safety ISO 13485 CE0297 Patent EP2170961 Main features A medical device based on non-cross-linked hyaluronic acid. Intended for injection, monophasic, sterile, pyrogen-free. Passing techniques microdeposit technique with the use of a needle retrograde linear technique using a cannula 6 application procedures
